Published in Lab Business Week, November 26th, 2006
In the studies, Masimo SET was shown to "work better for patient safety" during the most difficult clinical conditions of motion and low peripheral perfusion.
Masimo SET is the foundational technology that allowed the company to introduce Masimo Rainbow SET Pulse CO-Oximetry - the first and only monitoring platform...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.